These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11305599)

  • 1. Study on glutathionesulphonic acid as biodistribution promoter: concomitant use effect on verapamil hydrochloride and tegafur.
    Ohkawa Y; Higashiyama K; Sugaya S; Asoh T; Maeda H; Sasaki K; Nakayama T
    Biol Pharm Bull; 2001 Apr; 24(4):378-84. PubMed ID: 11305599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on glutathionesulfonic acid sodium salt as biodistribution promoter for thiopental sodium.
    Ohkawa Y; Fujimoto T; Higashiyama K; Maeda H; Asoh T; Kurumi M; Sasaki K; Nakayama T
    Biol Pharm Bull; 2002 Jun; 25(6):761-5. PubMed ID: 12081143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Sipjeondaebo-Tang on the Pharmacokinetics of S-1, an Anticancer Agent, in Rats Evaluated by Population Pharmacokinetic Modeling.
    Kim TH; Shin S; Shin JC; Bulitta JB; Weon KY; Yoo SD; Park GY; Jeong SW; Kwon DR; Min BS; Woo MH; Shin BS
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28880240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene.
    Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
    Can J Physiol Pharmacol; 2008 May; 86(5):232-9. PubMed ID: 18432283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous analysis of the enantiomers of verapamil and norverapamil in rat plasma by liquid chromatography-tandem mass spectrometry.
    Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
    J Pharm Biomed Anal; 2007 Dec; 45(5):762-8. PubMed ID: 17981422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo distribution of a novel proliposomal preparation of tegafur following intragastric gavage to rats].
    Gao XL; Kzybek M; Wen H
    Yao Xue Xue Bao; 2005 Dec; 40(12):1139-43. PubMed ID: 16496681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro percutaneous absorption of verapamil.
    Jain GK; Agrawal SS
    Indian J Exp Biol; 1996 May; 34(5):475-7. PubMed ID: 9063080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pioglitazone on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rats.
    Choi JS; Burm JP
    Arch Pharm Res; 2008 Sep; 31(9):1200-4. PubMed ID: 18806964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of midazolam on pharmacokinetics of verapamil in rabbits.
    Orszulak-Michalak D; Owczarek J; Wiktorowska-Owczarek AK
    Pol J Pharmacol; 2002; 54(5):501-6. PubMed ID: 12593537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats.
    Bansal T; Mishra G; Jaggi M; Khar RK; Talegaonkar S
    Eur J Pharm Sci; 2009 Mar; 36(4-5):580-90. PubMed ID: 19135530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro identification of metabolites of verapamil in rat liver microsomes.
    Sun L; Zhang SQ; Zhong DF
    Acta Pharmacol Sin; 2004 Jan; 25(1):121-8. PubMed ID: 14704133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D; Sharma R; Jain D
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of famotidine on verapamil pharmacokinetics in rats.
    Matar KM
    Eur J Drug Metab Pharmacokinet; 2005; 30(3):219-22. PubMed ID: 16250259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of grapefruit juice and smoking on verapamil concentrations in steady state.
    Fuhr U; Müller-Peltzer H; Kern R; Lopez-Rojas P; Jünemann M; Harder S; Staib AH
    Eur J Clin Pharmacol; 2002 Apr; 58(1):45-53. PubMed ID: 11956673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chiral separation of verapamil and some of its metabolites by HPLC and CE.
    Brandsteterová E; Endresz G; Blaschke G
    Pharmazie; 2001 Jul; 56(7):536-41. PubMed ID: 11487971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: study in healthy volunteers.
    Popović J; Mitić R; Sabo A; Mikov M; Jakovljević V; Daković-Svajcer K
    Eur J Drug Metab Pharmacokinet; 2006; 31(2):87-96. PubMed ID: 16898076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
    Choi DH; Chang KS; Hong SP; Choi JS; Han HK
    Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats.
    Yoshisue K; Masuda H; Matsushima E; Ikeda K; Nagayama S; Kawaguchi Y
    Drug Metab Dispos; 2000 Oct; 28(10):1162-7. PubMed ID: 10997934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of verapamil and norverapamil in the eye and systemic circulation after topical administration of verapamil in rabbits.
    Siegner SW; Giovanoni RL; Erickson KA; Netland PA
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):159-68. PubMed ID: 9572542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.